146 related articles for article (PubMed ID: 1712540)
21. The immunophenotype of ependymomas.
Vege KD; Giannini C; Scheithauer BW
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):25-31. PubMed ID: 10937045
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical profile and treatment of uncommon types of thyroid carcinomas.
Shvero J; Koren R; Shpitzer T; Feinmesser R; Segal K
Oncol Rep; 2003; 10(6):2075-8. PubMed ID: 14534746
[TBL] [Abstract][Full Text] [Related]
23. [A case report of a giant cell carcinoma of the thyroid].
Murakami N; Kawaura Y; Sasaki M; Munemoto Y; Iwa T; Nonomura A
Gan No Rinsho; 1989 Jul; 35(8):927-32. PubMed ID: 2746867
[TBL] [Abstract][Full Text] [Related]
24. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases.
Venkatesh YS; Ordonez NG; Schultz PN; Hickey RC; Goepfert H; Samaan NA
Cancer; 1990 Jul; 66(2):321-30. PubMed ID: 1695118
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
[TBL] [Abstract][Full Text] [Related]
28. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic thyroid carcinoma. A clinical, histologic, and immunohistochemical study.
Shvero J; Gal R; Avidor I; Hadar T; Kessler E
Cancer; 1988 Jul; 62(2):319-25. PubMed ID: 2968150
[TBL] [Abstract][Full Text] [Related]
30. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract][Full Text] [Related]
31. Squamous differentiation in thyroid carcinoma. With special reference to histogenesis of squamous cell carcinoma of the thyroid.
Katoh R; Sakamoto A; Kasai N; Yagawa K
Acta Pathol Jpn; 1989 May; 39(5):306-12. PubMed ID: 2481935
[TBL] [Abstract][Full Text] [Related]
32. Thyroid anaplastic carcinoma transformed from papillary carcinoma in extrathyroid area.
Togashi S; Oka K; Kanayama R; Koyamatsu S; Tobita T; Yatabe Y; Matsumoto T; Hakozaki H
Auris Nasus Larynx; 2004 Sep; 31(3):287-92. PubMed ID: 15364366
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells.
Nojima T; Nakamura F; Ishikura M; Inoue K; Nagashima K; Kato H
Int J Pancreatol; 1993 Dec; 14(3):275-81. PubMed ID: 8113629
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characterization of thyroid gland angiomatoid tumors.
Cutlan RT; Greer JE; Wong FS; Eltorky M
Exp Mol Pathol; 2000 Oct; 69(2):159-64. PubMed ID: 11001864
[TBL] [Abstract][Full Text] [Related]
37. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
38. The localization of cytoskeletal proteins and thyroglobulin in thyroid microcarcinoma in comparison with clinically manifested thyroid carcinoma.
Yagi Y; Yagi S; Saku T
Cancer; 1985 Oct; 56(8):1967-71. PubMed ID: 2411384
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical localization of cytoskeletal proteins and thyroglobulin in thyroid micro cancers].
Yagi S; Yagi Y; Saku T; Hatae M
Gan No Rinsho; 1984 Jun; 30(7):765-71. PubMed ID: 6205176
[TBL] [Abstract][Full Text] [Related]
40. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
